{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ACE2", "COVID-19", "Drug design", "Epicatechin", "Medicinal plants", "SARS-CoV-2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34942397", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "07"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1016/j.compbiomed.2021.105155", "S0010-4825(21)00949-5"], "Journal": {"ISSN": "1879-0534", "JournalIssue": {"Volume": "141", "PubDate": {"Year": "2022", "Month": "Feb"}}, "Title": "Computers in biology and medicine", "ISOAbbreviation": "Comput Biol Med"}, "ArticleTitle": "Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study.", "Pagination": {"StartPage": "105155", "MedlinePgn": "105155"}, "Abstract": {"AbstractText": ["Angiotensin-converting enzyme 2 (ACE2) is the first target of SARS-CoV-2 and a key functional host receptor through which this virus hooks into and infects human cells. The necessity to block this receptor is one of the essential means to prevent the outbreak of COVID-19. This study was conducted to determine the most eligible natural compound to suppress ACE2 to counterfeit its interaction with the viral infection. To do this, the most known compounds of sixty-six Iraqi medicinal plants were generated and retrieved from PubChem database. After preparing a library for Iraqi medicinal plants, 3663 unique ligands' conformers were docked to ACE2 using the GLIDE tool. Results found that twenty-three compounds exhibited the highest binding affinity with ACE2. The druglikeness and toxicity potentials of these compounds were evaluated using SwissADME and Protox servers respectively. Out of these virtually screened twenty-three compounds, epicatechin and kempferol were predicted to exert the highest druglikeness and lowest toxicity potentials. Extended Molecular dynamics (MD) simulations showed that ACE2-epicatechin complex exhibited a slightly higher binding stability than ACE2-kempferol complex. In addition to the well-known ACE2 inhibitors that were identified in previous studies, this study revealed for the first time that epicatechin from Hypericum perforatum provided a better static and dynamic inhibition for ACE2 with highly favourable pharmacokinetic properties than the other known ACE2 inhibiting compounds. This study entailed the ability of epicatechin to be used as a potent natural inhibitor that can be used to block or at least weaken the SARS-CoV-2 entry and its subsequent invasion. In vitro experiments are required to validate epicatechin effectiveness against the activity of the human ACE2 receptor."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Production, College of Agriculture, Al-Qasim Green University, Al-Qasim, 51013, Babil, Iraq. Electronic address: mohammed79@agre.uoqasim.edu.iq."}], "LastName": "Al-Shuhaib", "ForeName": "Mohammed Baqur S", "Initials": "MBS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, College of Pharmacy, University of Babylon, Babil, 51001, Iraq. Electronic address: phar.hayder.obayes@uobabylon.edu.iq."}], "LastName": "Hashim", "ForeName": "Hayder O", "Initials": "HO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Babylon Directorate of Education, Ministry of Education, Babil, 51001, Iraq. Electronic address: alshuhaibjmb@gmail.com."}], "LastName": "Al-Shuhaib", "ForeName": "Jafar M B", "Initials": "JMB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Comput Biol Med", "NlmUniqueID": "1250250", "ISSNLinking": "0010-4825"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "8R1V1STN48", "NameOfSubstance": "Catechin"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "ACE2 protein, human"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Catechin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Internalization"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J., Navis G.J., Gordijn S.J., Bolling M.C., Dijkstra G., Voors A.A., Osterhaus A.D.M.E. Angiotensin\u2010converting enzyme\u20102 (ACE2), SARS\u2010CoV\u20102 and pathophysiology of coronavirus disease 2019 (COVID\u201019) The Journal of Pathology. 2020;51:228\u2013248.", "ArticleIdList": ["PMC7276767", "32418199"]}, {"Citation": "Wysocki J., Schulze A., Batlle D. Novel variants of angiotensin converting enzyme-2 of shorter molecular size to target the kidney renin angiotensin system. Biomolecules. 2019;9:886.", "ArticleIdList": ["PMC6995632", "31861139"]}, {"Citation": "Jiang F., Yang J., Zhang Y., Dong M., Wang S., Zhang Q., Liu F.F., Zhang K., Zhang C. Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets. Nature Reviews Cardiology. 2014;11:413.", "ArticleIdList": ["PMC7097196", "24776703"]}, {"Citation": "Chen H., Muhammad I., Zhang Y., Ren Y., Zhang R., Huang X., Diao L., Liu H., Li X., Sun X. Antiviral activity against infectious bronchitis virus and bioactive components of Hypericum perforatum L. Frontiers in Pharmacology. 2019;10:1272.", "ArticleIdList": ["PMC6830131", "31736754"]}, {"Citation": "Kirchdoerfer R.N., Wang N., Pallesen J., Wrapp D., Turner H.L., Cottrell C.A., Corbett K.S., Graham B.S., McLellan J.S., Ward A.B. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Scientific Reports. 2018;8:1\u201311.", "ArticleIdList": ["PMC6200764", "30356097"]}, {"Citation": "Song W., Gui M., Wang X., Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathogens. 2018;14", "ArticleIdList": ["PMC6107290", "30102747"]}, {"Citation": "Hashim H.O., Mohammed M.K., Mousa M.J., Abdulameer H.H., Alhassnawi A.T.S., Hassan S.A., Al-Shuhaib M.B.S. Infection with different strains of SARS-CoV-2 in patients with COVID-19. Archives of Biological Sciences. 2020;72:575\u2013585."}, {"Citation": "Boopathi S., Poma A.B., Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics. 2021;39:3409\u20133418.", "ArticleIdList": ["PMC7196923", "32306836"]}, {"Citation": "McKee D.L., Sternberg A., Stange U., Laufer S., Naujokat C. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacological Research. 2020;157:104859.", "ArticleIdList": ["PMC7189851", "32360480"]}, {"Citation": "Grein J., Ohmagari N., Shin D., Diaz G., Asperges E., Castagna A., Feldt T., Green G., Green M.L., Lescure F.-X. Compassionate use of remdesivir for patients with severe Covid-19. New England Journal of Medicine. 2020;382:2327\u20132336.", "ArticleIdList": ["PMC7169476", "32275812"]}, {"Citation": "Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends. 2020;16:72\u201373.", "ArticleIdList": ["32074550"]}, {"Citation": "Contentti E.C., Correa J. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: a new challenge. Multiple Sclerosis and Related Disorders. 2020;41:102097.", "ArticleIdList": ["PMC7131249", "32278860"]}, {"Citation": "Wang H., Wang C., Han W., Geng C., Chen D., Wu B., Zhang J., Wang C., Jiang P. Association of leptin and leptin receptor polymorphisms with coronary artery disease in a North Chinese Han population. Revista Da Sociedade Brasileira de Medicina Tropical. 2020;53", "ArticleIdList": ["PMC7083392", "32049202"]}, {"Citation": "Farooq S., Ngaini Z. Natural and synthetic drugs as potential treatment for coronavirus disease 2019 (COVID-2019) Chemistry Africa. 2021;4:1\u201313."}, {"Citation": "Liskova A., Samec M., Koklesova L., Samuel S.M., Zhai K., Al-Ishaq R.K., Abotaleb M., Nosal V., Kajo K., Ashrafizadeh M. Biomedicine & Pharmacotherapy; 2021. Flavonoids against the SARS-CoV-2 Induced Inflammatory Storm; p. 111430.", "ArticleIdList": ["PMC7906511", "33662680"]}, {"Citation": "Wang Y., Fang S., Wu Y., Cheng X., Zhang L., Shen X., Li S., Xu J., Shang W., Gao Z. Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates. Acta Pharmacologica Sinica. 2021:1\u20137.", "ArticleIdList": ["PMC8295639", "34294887"]}, {"Citation": "Thangavel N., Al Bratty M., Al Hazmi H.A., Najmi A., Alaqi R.O.A. Molecular docking and molecular dynamics aided virtual search of OliveNetTM Directory for Secoiridoids to combat SARS-CoV-2 infection and associated hyperinflammatory responses. Frontiers in Molecular Biosciences. 2020;7", "ArticleIdList": ["PMC7817976", "33490110"]}, {"Citation": "Nasirzadeh A., Bazeli J., Hajavi J., Yavarmanesh N., Zahedi M., Abounoori M., Razavi A., Maddah M.M., Mortazavi P., Moradi M. 2021. Inhibiting IL-6 during Cytokine Storm in COVID-19: Potential Role of Natural Products."}, {"Citation": "Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.-M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E.H. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnology Advances. 2015;33:1582\u20131614.", "ArticleIdList": ["PMC4748402", "26281720"]}, {"Citation": "Abdelli I., Hassani F., Bekkel Brikci S., Ghalem S. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. Journal of Biomolecular Structure and Dynamics. 2021;39:3263\u20133276.", "ArticleIdList": ["PMC7232889", "32362217"]}, {"Citation": "Chen H., Du Q. 2020. Potential Natural Compounds for Preventing SARS-CoV-2 (2019-nCoV) Infection."}, {"Citation": "Takahashi S., Yoshiya T., Yoshizawa-Kumagaye K., Sugiyama T. Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean. Biomedical Research. 2015;36:219\u2013224.", "ArticleIdList": ["26106051"]}, {"Citation": "Balkrishna A., Pokhrel S., Singh J., Varshney A. 2020. Withanone from Withania Somnifera May Inhibit Novel Coronavirus (COVID-19) Entry by Disrupting Interactions between Viral S-Protein Receptor Binding Domain and Host ACE2 Receptor."}, {"Citation": "Wahedi H.M., Ahmad S., Abbasi S.W. Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics. 2021;39:3225\u20133234.", "ArticleIdList": ["32345140"]}, {"Citation": "Alexpandi R., De Mesquita J.F., Pandian S.K., Ravi A.V. Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and Spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in silico analysis. Frontiers in Microbiology. 2020;11:1796.", "ArticleIdList": ["PMC7390959", "32793181"]}, {"Citation": "Al-douri N.A. A survey of medicinal plants and their traditional uses in Iraq. Pharmaceutical Biology. 2000;38:74\u201379.", "ArticleIdList": ["21214444"]}, {"Citation": "Ahmed H.M. Ethnopharmacobotanical study on the medicinal plants used by herbalists in Sulaymaniyah Province, Kurdistan, Iraq. Journal of Ethnobiology and Ethnomedicine. 2016;12:1\u201317.", "ArticleIdList": ["PMC4730727", "26821541"]}, {"Citation": "Kawarty A.M.A.M.A., Beh\u00e7et L., \u00c7akilcio\u011flu U. An ethnobotanical survey of medicinal plants in Ballakayati (Erbil, North Iraq) Turkish Journal of Botany. 2020;44:345\u2013357."}, {"Citation": "Warner F.J., Smith A.I., Hooper N.M., Turner A.J. Angiotensin-converting enzyme-2: a molecular and cellular perspective. Cellular and Molecular Life Sciences: CMLS. 2004;61:2704\u20132713.", "ArticleIdList": ["PMC7079784", "15549171"]}, {"Citation": "Friesner R.A., Banks J.L., Murphy R.B., Halgren T.A., Klicic J.J., Mainz D.T., Repasky M.P., Knoll E.H., Shelley M., Perry J.K. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry. 2004;47:1739\u20131749.", "ArticleIdList": ["15027865"]}, {"Citation": "Muchtaridi M., Fauzi M., Khairul Ikram N.K., Mohd Gazzali A., Wahab H.A. Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2. Molecules. 2020;25:3980.", "ArticleIdList": ["PMC7504743", "32882868"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports. 2017;7:1\u201313.", "ArticleIdList": ["PMC5335600", "28256516"]}, {"Citation": "Banerjee P., Eckert A.O., Schrey A.K., Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Research. 2018;46:W257\u2013W263.", "ArticleIdList": ["PMC6031011", "29718510"]}, {"Citation": "Czaplewski C., Karczy\u0144ska A., Sieradzan A.K., Liwo A. UNRES server for physics-based coarse-grained simulations and prediction of protein structure, dynamics and thermodynamics. Nucleic Acids Research. 2018;46:W304\u2013W309.", "ArticleIdList": ["PMC6031057", "29718313"]}, {"Citation": "Kuncewicz K., Spodzieja M., Sieradzan A., Karczy\u0144ska A., D\u0105browska K., Dadlez M., Speiser D.E., Derre L., Rodziewicz-Motowid\u0142o S. A structural model of the immune checkpoint CD160\u2013HVEM complex derived from HDX-mass spectrometry and molecular modeling. Oncotarget. 2019;10:536.", "ArticleIdList": ["PMC6355189", "30728903"]}, {"Citation": "Krupa P., Karczy\u0144ska A.S., Mozolewska M.A., Liwo A., Czaplewski C. UNRES-Dock\u2014protein\u2013protein and peptide\u2013protein docking by coarse-grained replica-exchange MD simulations. Bioinformatics. 2021;37:1613\u20131615.", "ArticleIdList": ["33079977"]}, {"Citation": "Liwo A., Czaplewski C., Sieradzan A.K., Lipska A.G., Samsonov S.A., Murarka R.K. Theory and practice of coarse-grained molecular dynamics of biologically important systems. Biomolecules. 2021;11:1347.", "ArticleIdList": ["PMC8465211", "34572559"]}, {"Citation": "Schneidman-Duhovny D., Inbar Y., Nussinov R., Wolfson H.J. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Research. 2005;33:W363\u2013W367.", "ArticleIdList": ["PMC1160241", "15980490"]}, {"Citation": "Mashiach E., Schneidman-Duhovny D., Andrusier N., Nussinov R., Wolfson H.J. FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Research. 2008;36:W229\u2013W232.", "ArticleIdList": ["PMC2447790", "18424796"]}, {"Citation": "Pathania S., Singh P.K. 2021. Analyzing FDA-Approved Drugs for Compliance of Pharmacokinetic Principles: Should There Be a Critical Screening Parameter in Drug Designing Protocols?", "ArticleIdList": ["33320017"]}, {"Citation": "Krupa P., Spodzieja M., Sieradzan A.K. Prediction of CD28-CD86 protein complex structure using different level of resolution approach. Journal of Molecular Graphics and Modelling. 2021;103:107802.", "ArticleIdList": ["33246194"]}, {"Citation": "Ni W., Yang X., Yang D., Bao J., Li R., Xiao Y., Hou C., Wang H., Liu J., Yang D. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care. 2020;24:1\u201310.", "ArticleIdList": ["PMC7356137", "32660650"]}, {"Citation": "Bosso M., Thanaraj T.A., Abu-Farha M., Alanbaei M., Abubaker J., Al-Mulla F. Molecular Therapy-Methods & Clinical Development; 2020. The Two Faces of ACE2: the Role of ACE2 Receptor and its Polymorphisms in Hypertension and COVID-19.", "ArticleIdList": ["PMC7314689", "32665962"]}, {"Citation": "Zhang P., Zhu L., Cai J., Lei F., Qin J.-J., Xie J., Liu Y.-M., Zhao Y.-C., Huang X., Lin L. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation Research. 2020;126:1671\u20131681.", "ArticleIdList": ["PMC7265882", "32302265"]}, {"Citation": "Enmozhi S.K., Raja K., Sebastine I., Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. Journal of Biomolecular Structure and Dynamics. 2021;39:3092\u20133098.", "ArticleIdList": ["PMC7212536", "32329419"]}, {"Citation": "Shawan M.M.A.K., Halder S.K., Hasan M.A. Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak. Bulletin of the National Research Centre. 2021;45:1\u201321.", "ArticleIdList": ["PMC7816153", "33495684"]}, {"Citation": "Abubakar M.B., Usman D., Batiha G.E.-S., Cruz-Martins N., Malami I., Ibrahim K.G., Abubakar B., Bello M.B., Muhammad A., Gan S.H. Natural products modulating Angiotensin Converting Enzyme 2 (ACE2) as potential COVID-19 therapies. Frontiers in Pharmacology. 2021;12", "ArticleIdList": ["PMC8126690", "34012391"]}, {"Citation": "Han D.P., Penn-Nicholson A., Cho M.W. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology. 2006;350:15\u201325.", "ArticleIdList": ["PMC7111894", "16510163"]}, {"Citation": "Ghoran S.H., El-Shazly M., Sekeroglu N., Kijjoa A. Natural products from medicinal plants with anti-human coronavirus activities. Molecules. 2021;26:1754.", "ArticleIdList": ["PMC8003969", "33800977"]}, {"Citation": "Ojeda D., Jim\u00e9nez-Ferrer E., Zamilpa A., Herrera-Arellano A., Tortoriello J., Alvarez L. Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin-and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. Journal of Ethnopharmacology. 2010;127:7\u201310.", "ArticleIdList": ["19808084"]}, {"Citation": "Sharma P., Shanavas A. Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis. Journal of Biomolecular Structure and Dynamics. 2021;39:5819\u20135830.", "ArticleIdList": ["PMC7441762", "32691697"]}, {"Citation": "Actis-Goretta L., Ottaviani J.I., Fraga C.G. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. Journal of Agricultural and Food Chemistry. 2006;54:229\u2013234.", "ArticleIdList": ["16390204"]}, {"Citation": "Hausmann M., Obermeier F., Paper D.H., Balan K., Dunger N., Menzel K., Falk W., Schoelmerich J., Herfarth H., Rogler G. In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium\u2010induced colitis. Clinical & Experimental Immunology. 2007;148:373\u2013381.", "ArticleIdList": ["PMC1868873", "17437425"]}, {"Citation": "Bernatova I., Liskova S. Mechanisms modified by (\u2212)-Epicatechin and taxifolin relevant for the treatment of hypertension and viral infection: knowledge from preclinical studies. Antioxidants. 2021;10:467.", "ArticleIdList": ["PMC8002320", "33809620"]}, {"Citation": "Lin Y.-T., Wu Y.-H., Tseng C.-K., Lin C.-K., Chen W.-C., Hsu Y.-C., Lee J.-C. Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation. PloS One. 2013;8", "ArticleIdList": ["PMC3554764", "23365670"]}, {"Citation": "Ferreira P.G., Ferraz A.C., Figueiredo J.E., Lima C.F., Rodrigues V.G., Taranto A.G., Ferreira J.M.S., Brand\u00e3o G.C., Vieira-Filho S.A., Duarte L.P. Detection of the antiviral activity of epicatechin isolated from Salacia crassifolia (Celastraceae) against Mayaro virus based on protein C homology modelling and virtual screening. Archives of Virology. 2018;163:1567\u20131576.", "ArticleIdList": ["29478125"]}, {"Citation": "Codorniu-Hern\u00e1ndez E., Rolo-Naranjo A., Montero-Cabrera L.A. Theoretical affinity order among flavonoids and amino acid residues: an approach to understand flavonoid\u2013protein interactions. Journal of Molecular Structure: THEOCHEM. 2007;819:121\u2013129."}, {"Citation": "Zirak N., Shafiee M., Soltani G., Mirzaei M., Sahebkar A. Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: current evidence and potential mechanisms of action. Journal of Cellular Physiology. 2019;234:8496\u20138508.", "ArticleIdList": ["30461013"]}, {"Citation": "Cayci M.K., Dayioglu H. Hypericum perforatum extracts healed gastric lesions induced by hypothermic restraint stress in Wistar rats. Saudi Med J. 2009;30:750\u2013754.", "ArticleIdList": ["19526154"]}, {"Citation": "Brattstr\u00f6m A. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression. Phytomedicine. 2009;16:277\u2013283.", "ArticleIdList": ["19299116"]}, {"Citation": "Altan A., Aras M.H., Damlar \u0130., G\u00f6k\u00e7e H., \u00d6zcan O., Alpaslan C. The effect of Hypericum Perforatum on wound healing of oral mucosa in diabetic rats. European Oral Research. 2018;52:143\u2013149.", "ArticleIdList": ["PMC6365136", "30775718"]}, {"Citation": "Seyhan N. Evaluation of the healing effects of Hypericum perforatum and curcumin on burn wounds in rats. Evidence-Based Complementary and Alternative Medicine. 2020:2020.", "ArticleIdList": ["PMC7042516", "32148546"]}, {"Citation": "Ozkan E.E., Ozden T.Y., Ozsoy N., Mat A. Evaluation of chemical composition, antioxidant and anti-acetylcholinesterase activities of Hypericum neurocalycinum and Hypericum malatyanum. South African Journal of Botany. 2018;114:104\u2013110."}, {"Citation": "Kacerovsk\u00e1 D., Pizinger K., Majer F., \u0160m\u00edd F. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract\u2014a pilot study. Photochemistry and Photobiology. 2008;84:779\u2013785.", "ArticleIdList": ["18179625"]}, {"Citation": "Hammer K.D.P., Hillwig M.L., Solco A.K.S., Dixon P.M., Delate K., Murphy P.A., Wurtele E.S., Birt D.F. Inhibition of prostaglandin E2 production by anti-inflammatory Hypericum perforatum extracts and constituents in RAW264. 7 mouse macrophage cells. Journal of Agricultural and Food Chemistry. 2007;55:7323\u20137331.", "ArticleIdList": ["PMC2365463", "17696442"]}, {"Citation": "Yal\u00e7\u0131n S., Yal\u00e7\u0131nkaya S., Ercan F. Determination of potential drug candidate molecules of the Hypericum perforatum for COVID-19 treatment. Current Pharmacology Reports. 2021:1\u20137.", "ArticleIdList": ["PMC7921287", "33680715"]}, {"Citation": "Jena A.B., Kanungo N., Nayak V., Chainy G.B.N., Dandapat J. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Scientific Reports. 2021;11:1\u201314.", "ArticleIdList": ["PMC7820253", "33479401"]}, {"Citation": "Ottaviani J.I., Momma T.Y., Heiss C., Kwik-Uribe C., Schroeter H., Keen C.L. The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radical Biology and Medicine. 2011;50:237\u2013244.", "ArticleIdList": ["21074608"]}, {"Citation": "Mallipeddi P.L., Kumar G., White S.W., Webb T.R. Recent advances in computer-aided drug design as applied to anti-influenza drug discovery. Current Topics in Medicinal Chemistry. 2014;14:1875\u20131889.", "ArticleIdList": ["25262796"]}, {"Citation": "Macip G., Garcia\u2010Segura P., Mestres\u2010Truyol J., Saldivar\u2010Espinoza B., Ojeda\u2010Montes M.J., Gimeno A., Cereto\u2010Massagu\u00e9 A., Garcia\u2010Vallv\u00e9 S., Pujadas G. Haste makes waste: a critical review of docking\u2010based virtual screening in drug repurposing for SARS\u2010CoV\u20102 main protease (M\u2010pro) inhibition. Medicinal Research Reviews. 2021 doi: 10.1002/med.21862. In press.", "ArticleIdList": ["10.1002/med.21862", "PMC8662214", "34697818"]}, {"Citation": "Llanos M.A., Gantner M.E., Rodriguez S., Alberca L.N., Bellera C.L., Talevi A., Gavernet L. Strengths and weaknesses of docking simulations in the SARS-CoV-2 era: the main protease (Mpro) case study. Journal of Chemical Information and Modeling. 2021;61:3758\u20133770.", "ArticleIdList": ["34313128"]}, {"Citation": "Phillips M.A., Stewart M.A., Woodling D.L., Xie Z.-R. Has molecular docking ever brought us a medicine. Molecular Docking. 2018:141."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "22"}, {"Year": "2021", "Month": "12", "Day": "15"}, {"Year": "2021", "Month": "12", "Day": "15"}, {"Year": "2021", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "23", "Hour": "20", "Minute": "16"}, {"Year": "2021", "Month": "12", "Day": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34942397", "PMC8679518", "10.1016/j.compbiomed.2021.105155", "S0010-4825(21)00949-5"]}}], "PubmedBookArticle": []}